UniProt ID | RU1C_HUMAN | |
---|---|---|
UniProt AC | P09234 | |
Protein Name | U1 small nuclear ribonucleoprotein C {ECO:0000255|HAMAP-Rule:MF_03153} | |
Gene Name | SNRPC {ECO:0000255|HAMAP-Rule:MF_03153} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 159 | |
Subcellular Localization | Nucleus . | |
Protein Description | Component of the spliceosomal U1 snRNP, which is essential for recognition of the pre-mRNA 5' splice-site and the subsequent assembly of the spliceosome. SNRPC/U1-C is directly involved in initial 5' splice-site recognition for both constitutive and regulated alternative splicing. The interaction with the 5' splice-site seems to precede base-pairing between the pre-mRNA and the U1 snRNA. Stimulates commitment or early (E) complex formation by stabilizing the base pairing of the 5' end of the U1 snRNA and the 5' splice-site region.. | |
Protein Sequence | MPKFYCDYCDTYLTHDSPSVRKTHCSGRKHKENVKDYYQKWMEEQAQSLIDKTTAAFQQGKIPPTPFSAPPPAGAMIPPPPSLPGPPRPGMMPAPHMGGPPMMPMMGPPPPGMMPVGPAPGMRPPMGGHMPMMPGPPMMRPPARPMMVPTRPGMTRPDR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Ubiquitination | -----MPKFYCDYCD -----CCCCCCCCCC | 47.90 | 21890473 | |
3 | Acetylation | -----MPKFYCDYCD -----CCCCCCCCCC | 47.90 | 25825284 | |
5 | Phosphorylation | ---MPKFYCDYCDTY ---CCCCCCCCCCCE | 7.19 | 21945579 | |
8 | Phosphorylation | MPKFYCDYCDTYLTH CCCCCCCCCCCEECC | 6.67 | 21945579 | |
9 | Glutathionylation | PKFYCDYCDTYLTHD CCCCCCCCCCEECCC | 1.69 | 22555962 | |
11 | Phosphorylation | FYCDYCDTYLTHDSP CCCCCCCCEECCCCC | 19.50 | 21945579 | |
12 | Phosphorylation | YCDYCDTYLTHDSPS CCCCCCCEECCCCCH | 9.06 | 21945579 | |
14 | Phosphorylation | DYCDTYLTHDSPSVR CCCCCEECCCCCHHH | 17.14 | 21945579 | |
17 | Phosphorylation | DTYLTHDSPSVRKTH CCEECCCCCHHHHCC | 16.09 | 22167270 | |
19 | Phosphorylation | YLTHDSPSVRKTHCS EECCCCCHHHHCCCC | 38.21 | 21945579 | |
35 | Ubiquitination | RKHKENVKDYYQKWM CCCHHHHHHHHHHHH | 52.15 | - | |
35 | Succinylation | RKHKENVKDYYQKWM CCCHHHHHHHHHHHH | 52.15 | 23954790 | |
35 | Acetylation | RKHKENVKDYYQKWM CCCHHHHHHHHHHHH | 52.15 | 26051181 | |
37 | Phosphorylation | HKENVKDYYQKWMEE CHHHHHHHHHHHHHH | 11.32 | 28796482 | |
38 | Phosphorylation | KENVKDYYQKWMEEQ HHHHHHHHHHHHHHH | 17.47 | 28796482 | |
40 | Ubiquitination | NVKDYYQKWMEEQAQ HHHHHHHHHHHHHHH | 32.18 | 21890473 | |
48 | Phosphorylation | WMEEQAQSLIDKTTA HHHHHHHHHHHHHHH | 30.24 | 19060867 | |
52 | 2-Hydroxyisobutyrylation | QAQSLIDKTTAAFQQ HHHHHHHHHHHHHHC | 40.56 | - | |
52 | Ubiquitination | QAQSLIDKTTAAFQQ HHHHHHHHHHHHHHC | 40.56 | 2190698 | |
52 | Acetylation | QAQSLIDKTTAAFQQ HHHHHHHHHHHHHHC | 40.56 | 19608861 | |
53 | Phosphorylation | AQSLIDKTTAAFQQG HHHHHHHHHHHHHCC | 20.23 | 28102081 | |
54 | Phosphorylation | QSLIDKTTAAFQQGK HHHHHHHHHHHHCCC | 23.02 | 28102081 | |
61 | Ubiquitination | TAAFQQGKIPPTPFS HHHHHCCCCCCCCCC | 47.94 | 21890473 | |
88 | Dimethylation | PSLPGPPRPGMMPAP CCCCCCCCCCCCCCC | 43.46 | - | |
88 | Methylation | PSLPGPPRPGMMPAP CCCCCCCCCCCCCCC | 43.46 | 52718127 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RU1C_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RU1C_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RU1C_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-52, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-8 AND TYR-12, AND MASSSPECTROMETRY. |